Pnina Fishman
Founder chez CAN-FITE BIOPHARMA LTD.
Fortune : 2 013 $ au 31/03/2024
Profil
Pnina Fishman is the founder of Can-Fite BioPharma Ltd., which was founded in 1994.
She currently holds the position of Executive Chairman & Chief Scientific Officer at Can-Fite BioPharma Ltd.
Dr. Fishman is also currently serving as a Director at Eyefite Ltd., Consulting F.D.
International Marketing & Engingeering Ltd., Ultratrend Ltd., and Fd Consulting Ltd.
In the past, she served as the Chief Executive Officer at Mor Research Applications Ltd.
and as the Chairman at OphthaliX, Inc. from 2013 to 2014.
Dr. Fishman also held the title of Professor at Rabin Medical Center Beilinson.
She obtained a doctorate degree from Bar-Ilan University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CAN-FITE BIOPHARMA LTD.
0,02% | 28/03/2024 | 263 433 ( 0,02% ) | 2 013 $ | 31/03/2024 |
Postes actifs de Pnina Fishman
| Sociétés | Poste | Début |
|---|---|---|
| CAN-FITE BIOPHARMA LTD. | Founder | 11/09/1994 |
| Consulting F.D. International Marketing & Engingeering Ltd. | Director/Board Member | - |
Eyefite Ltd.
 Eyefite Ltd. BiotechnologyHealth Technology Eyefite Ltd. provides ophthalmology research and develops pharmaceutical products. The company is headquartered in Ramat Gan, Israel. | Director/Board Member | - |
| Ultratrend Ltd. | Director/Board Member | - |
| Fd Consulting Ltd. | Director/Board Member | - |
Anciens postes connus de Pnina Fishman
| Sociétés | Poste | Fin |
|---|---|---|
Rabin Medical Center Beilinson
 Rabin Medical Center Beilinson Hospital/Nursing ManagementHealth Services Rabin Medical Center Beilinson provides hospital medical services. The private company is based in Petach Tikva, Israel. The CEO of the Israeli company is Eyran Halpern. | Corporate Officer/Principal | - |
| Mor Research Applications Ltd. | Chief Executive Officer | - |
OphthaliX, Inc.
 OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Chief Executive Officer | - |
Formation de Pnina Fishman
| Bar-Ilan University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CAN-FITE BIOPHARMA LTD. | Health Technology |
| Entreprise privées | 7 |
|---|---|
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Health Technology |
| Mor Research Applications Ltd. | |
Rabin Medical Center Beilinson
Rabin Medical Center Beilinson Hospital/Nursing ManagementHealth Services Rabin Medical Center Beilinson provides hospital medical services. The private company is based in Petach Tikva, Israel. The CEO of the Israeli company is Eyran Halpern. | Health Services |
Eyefite Ltd.
Eyefite Ltd. BiotechnologyHealth Technology Eyefite Ltd. provides ophthalmology research and develops pharmaceutical products. The company is headquartered in Ramat Gan, Israel. | Health Technology |
| Consulting F.D. International Marketing & Engingeering Ltd. | |
| Ultratrend Ltd. | |
| Fd Consulting Ltd. |
